Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.36 - $0.63 $1,440 - $2,520
4,000 Added 2.65%
154,991 $57,000
Q4 2022

Feb 09, 2023

SELL
$0.41 - $18.6 $820 - $37,200
-2,000 Reduced 1.31%
150,991 $72,000
Q3 2022

Nov 04, 2022

BUY
$0.57 - $34.65 $2,280 - $138,600
4,000 Added 2.68%
152,991 $132,000
Q1 2022

May 02, 2022

BUY
$1.16 - $2.5 $53,117 - $114,477
45,791 Added 44.37%
148,991 $197,000
Q4 2021

Feb 01, 2022

SELL
$2.46 - $8.74 $14,760 - $52,440
-6,000 Reduced 5.49%
103,200 $254,000
Q3 2021

Nov 01, 2021

BUY
$5.1 - $9.39 $40,800 - $75,120
8,000 Added 7.91%
109,200 $933,000
Q2 2020

Jul 31, 2020

BUY
$1.75 - $2.65 $177,100 - $268,180
101,200 New
101,200 $214,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $92.8M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Xml Financial, LLC Portfolio

Follow Xml Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xml Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xml Financial, LLC with notifications on news.